MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer
Clinical trial NCT03916679 · UNKNOWN
Trial details
- NCT number
- NCT03916679
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-20
- Primary completion
- 2022-04-20
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.